The promising yet complex process of personalized medicine requires synchronization and cooperation among healthcare providers, labs, cold chain suppliers, wholesalers, transporters, and drug manufacturers. To protect both patients and margins, this type of medicine requires zero errors and high levels of technology.
This report from Futurum looks at the advantages of leveraging technology to protect margins and:
Download their report to better understand how they see the industry evolving.